B vitamin important for cell division and DNA synthesis
12 of 22 providers
Vitamins &Nutrients
>3.0 ng/mL, Optimal:7-15 ng/mL
Folate (vitamin B9) is a water-soluble vitamin essential for DNA synthesis, cell division, methylation, and red blood cell formation. The term "folate"refers to the natural form found in foods (leafy greens, legumes, citrus), while "folic acid"is the synthetic form used in supplements and fortified foods. Folate is critical during periods of rapid cell division—pregnancy, infancy, adolescence—and deficiency causes neural tube defects (spina bifida) in developing fetuses, which is why folic acid fortification of grain products has been mandatory in the US since 1998.
Here's the critical insight:not all folate is created equal. Folic acid (synthetic) must be converted to the active form, 5-methyltetrahydrofolate (5-MTHF or methylfolate), via the MTHFR enzyme. ~40% of people have MTHFR gene variants (C677T or A1298C) that reduce enzyme activity by 30-70%, impairing folic acid metabolism. These individuals may have normal serum folate but functional deficiency at the cellular level. Methylfolate supplements bypass this issue entirely and are preferred, especially for those with MTHFR variants, depression, or cardiovascular disease.
Folate works in tandem with B12 in the methylation cycle, converting homocysteine→methionine. Deficiency of either vitamin causes elevated homocysteine (>10 mcmol/L), a risk factor for cardiovascular disease, stroke, cognitive decline, and Alzheimer's. If folate is low but B12 is also low, you MUST correct B12 first—giving folate alone can mask B12 deficiency anemia while allowing irreversible neurological damage to progress.
| Range Type | Level | Significance |
|---|---|---|
| Optimal (Longevity) | >20 ng/mL | Target for optimal methylation, brain health, CVD prevention. Many functional medicine doctors target >15-20 ng/mL. |
| Adequate (Standard) | >10 ng/mL | Meets standard guidelines. Sufficient to prevent megaloblastic anemia but may be suboptimal for methylation and homocysteine. |
| Suboptimal | 4-10 ng/mL | Low-normal. May have elevated homocysteine. Consider supplementation, especially if MTHFR variant or CVD risk factors. |
| Deficient | <4 ng/mL | Frank deficiency. Causes megaloblastic anemia, elevated homocysteine, increased NTD risk in pregnancy. Requires immediate folate supplementation. |
>20 ng/mL
Folate Supplementation (Dose and Form)
Dietary Sources of Folate
Optimize Methylation Cofactors
MTHFR Testing and Methylfolate
Excessive folic acid supplementation (>1000 mcg/day). Natural folate from food cannot cause toxicity.|Fortified foods + supplements:Easy to exceed 1000 mcg/day if consuming fortified grains + multivitamin + B-complex.|Rarely, kidney disease (impaired excretion).
Source:Baseline:Check serum folate if symptoms (fatigue, anemia, depression) or risk factors (low vegetable intake, malabsorption, alcohol use, MTHFR variant).|Check homocysteine:More sensitive marker of functional folate status. If homocysteine >10 mcmol/L, consider folate (and B12) deficiency even if serum folate appears normal.|After starting supplementation:Retest folate and homocysteine in 3 months. Goal:folate >15 ng/mL, homocysteine <8 mcmol/L.|Pregnancy:Baseline folate before conception. Supplement 400-800 mcg/day throughout pregnancy.|If on methotrexate:Monitor folate closely;may need leucovorin (folinic acid) rescue to prevent toxicity.
Folic acid supplementation (400-800 mcg/day) started before conception reduces NTD risk by 70%. US grain fortification (since 1998) reduced NTD prevalence by 25-30%. Neural tube closes by day 28 of pregnancy—before most women know they're pregnant—hence recommendation for all women of childbearing age to supplement.
Source:MRC Vitamin Study Research Group. Prevention of neural tube defects with folic acid. Lancet. 1991;338(8760):131-137.
Folate supplementation lowers homocysteine by 25-30%. Meta-analyses show folic acid supplementation (800 mcg/day) reduces stroke risk by 10-20%, with greater benefit in populations without grain fortification. CVD benefit is modest in RCTs, possibly because started too late in disease process or because homocysteine is a marker, not a cause.
Source:Wang X, et al. Efficacy of folic acid supplementation in stroke prevention:a meta-analysis. Lancet. 2007;369(9576):1876-1882.
Folate deficiency is common in depression (15-40% of depressed patients have low folate). Low folate associated with poor antidepressant response. Methylfolate (15 mg/day) improves treatment-resistant depression when added to SSRIs in RCTs. Methylfolate enhances serotonin, dopamine, and norepinephrine synthesis.
Source:Papakostas GI, et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression. Am J Psychiatry. 2012;169(12):1267-1274.
Low folate (<10 ng/mL) associated with 2-3x higher dementia risk. Folate + B12 + B6 supplementation slows cognitive decline and brain atrophy in elderly with elevated homocysteine. Benefits greatest when started early (MCI stage) before significant dementia.
Source:Durga J, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults. Lancet. 2007;369(9557):208-216.
| Provider | Includes | Annual Cost | Biomarkers |
|---|---|---|---|
| ✓ | $199 | 100+ (150 with ratios) | |
| — | $349 | 65 | |
| — | $398 | 30+ | |
| — | $486 | 40+ | |
| — | $468 | 83 | |
| ✓ | $349 | 100+ | |
| — | $680 | 54 | |
| ✓ | $365 | 100+ | |
| — | $250 | 65 | |
| ✓ | $495 | 70+ | |
| ✓ | $895 | 100+ | |
| ✓ | $1950 | 150+ | |
| — | $399 | 100+ | |
| — | $Varies | 75+ | |
| ✓ | $190 | 100+ | |
| — | $99 | 50 | |
| ✓ | $125 | 60 | |
| — | $199 | 50 | |
| ✓ | $499 | 120+ | |
| — | $4188 | 80+ | |
| ✓ | $375 | 85 | |
| ✓ | $700 | 129 |
12 providers include this biomarker in their panels
This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider about your specific health needs.